CytImmune Sciences' Series B Round

CytImmune Sciences raised a round of funding on December 15, 2005. Investors include Maryland Department of Business & Economic Development.

CytImmune Sciences is a clinical stage nanomedicine company with a core focus on the discovery, development and commercialization of multifunctional, tumor-targeted therapies. Based on an R&D strategy…

Articles about CytImmune Sciences' Series B Round: